Droxidopa in the Management of Hepatorenal Syndrome.
Andrea BejjaniYouqi ZhangAllison BehrensBrian P MurrayNeil D ShahPublished in: Journal of pharmacy practice (2022)
Droxidopa, an oral norepinephrine precursor, presents a novel adjunctive agent for management of HRS refractory to first-line medical management.
Keyphrases